Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules Size in Type 2 Diabetes: a 2-years Prospective Multicentric Study

NCT04298684 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de la Guadeloupe as lead sponsor.

NCT NCT04298684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04298684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules Size in Type 2 Diabetes: a 2-years Prospective Multicentric Study
Lead sponsor
Centre Hospitalier Universitaire de la Guadeloupe
Phase
Phase 4
Overall status
Unknown status
Start date
January 1, 2021
Completion date
July 1, 2024
Enrollment
90 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, thyroid nodule (benign)